American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 389-398 , March 2009

Cystatin C and Carotid Intima-Media Thickness in Asymptomatic Adults: The Multi-Ethnic Study of Atherosclerosis (MESA)

  • Anh L. Bui, MD

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA
    • ,
  • Ronit Katz, PhD

      Affiliations

    • Collaborative Health Studies Coordinating Center, Department of Biostatistics, University of Washington, Seattle, WA
    • ,
  • Bryan Kestenbaum, MD, MS

      Affiliations

    • Division of Nephrology, University of Washington, Seattle, WA
    • ,
  • Ian H. de Boer, MD, MS

      Affiliations

    • Division of Nephrology, University of Washington, Seattle, WA
    • ,
  • Linda F. Fried, MD, MPH

      Affiliations

    • Veterans Affairs Pittsburgh Healthcare System and Renal-Electrolyte Division, University of Pittsburgh, Pittsburgh, PA
    • ,
  • Joseph F. Polak, MD, MPH

      Affiliations

    • Department of Radiology, Tufts Medical Center, Boston, MA
    • ,
  • Bruce A. Wasserman, MD

      Affiliations

    • Department of Radiology, The Johns Hopkins Hospital, Baltimore, MD
    • ,
  • Mark J. Sarnak, MD, MS

      Affiliations

    • Department of Medicine, Tufts Medical Center, Boston, MA
    • ,
  • David Siscovick, MD, MPH

      Affiliations

    • Department of Medicine, University of Washington, Seattle, WA
    • ,
  • Michael G. Shlipak, MD, MPH

      Affiliations

    • Department of Medicine, University of California, San Francisco, CA
    • General Internal Medicine Section, San Francisco Veterans Affairs Medical Center, San Francisco, CA
    • Corresponding Author InformationAddress correspondence to Michael G. Shlipak, MD, MPH, General Internal Medicine Section (111A-1), Veterans Affairs Medical Center, 4150 Clement St, San Francisco, CA 94121

Received 17 March 2007 ,Accepted 24 June 2008.

References 

  1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
  2. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: A statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation. 2003;108:2154–2169
  3. Shlipak MG, Simon JA, Grady D, Lin F, Wenger NK, Furberg CD. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol. 2001;38:705–711
  4. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease: Evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1–S266
  5. Sarnak MJ, Levey AS. Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis. 2000;35(suppl 1):S117–S131
  6. Shlipak MG, Sarnak MJ, Katz R, et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med. 2005;352:2049–2060
  7. Shlipak MG, Katz R, Sarnak MJ, et al. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med. 2006;145:237–246
  8. D'Amico G. Statins and renal diseases: From primary prevention to renal replacement therapy. J Am Soc Nephrol. 2006;17(suppl 2):S148–S152
  9. Muntner P, Hamm LL, Kusek JW, Chen J, Whelton PK, He J. The prevalence of nontraditional risk factors for coronary heart disease in patients with chronic kidney disease. Ann Intern Med. 2004;140:9–17
  10. Shlipak MG, Fried LF, Crump C, et al. Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation. 2003;107:87–92
  11. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation. 1997;96:1432–1437
  12. Burke GL, Evans GW, Riley WA, et al. Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults (The Atherosclerosis Risk in Communities (ARIC) Study). Stroke. 1995;26:386–391
  13. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults (Cardiovascular Health Study Collaborative Research Group). N Engl J Med. 1999;340:14–22
  14. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the Carotid Atherosclerosis Progression Study (CAPS). Stroke. 2006;37:87–92
  15. Stompor T, Krasniak A, Sulowicz W, et al. Changes in common carotid artery intima-media thickness over 1 year in patients on peritoneal dialysis. Nephrol Dial Transplant. 2005;20:404–412
  16. Zoccali C, Benedetto FA, Maas R, et al. Asymmetric dimethylarginine, C-reactive protein, and carotid intima-media thickness in end-stage renal disease. J Am Soc Nephrol. 2002;13:490–496
  17. Burdick L, Periti M, Salvaggio A, et al. Relation between carotid artery atherosclerosis and time on dialysis (A non-invasive study in vivo). Clin Nephrol. 1994;42:121–126
  18. Hojs R. Carotid intima-media thickness and plaques in hemodialysis patients. Artif Organs. 2000;24:691–695
  19. Kawagishi T, Nishizawa Y, Konishi T, et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. Kidney Int. 1995;48:820–826
  20. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. J Am Soc Nephrol. 2001;12:2458–2464
  21. Kato A, Takita T, Maruyama Y, Kumagai H, Hishida A. Impact of carotid atherosclerosis on long-term mortality in chronic hemodialysis patients. Kidney Int. 2003;64:1472–1479
  22. Nishizawa Y, Shoji T, Maekawa K, et al. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis. 2003;41(suppl 3):S76–S79
  23. Shoji T, Emoto M, Tabata T, et al. Advanced atherosclerosis in predialysis patients with chronic renal failure. Kidney Int. 2002;61:2187–2192
  24. Preston E, Ellis MR, Kulinskaya E, Davies AH, Brown EA. Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kidney Dis. 2005;46:856–862
  25. Shlipak MG, Fried LF, Crump C, et al. Cardiovascular disease risk status in elderly persons with renal insufficiency. Kidney Int. 2002;62:997–1004
  26. Szeto CC, Chow KM, Woo KS, et al. Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. J Am Soc Nephrol. 2007;18:1966–1972
  27. Zoungas S, Ristevski S, Lightfoot P, et al. Carotid artery intima-medial thickness is increased in chronic renal failure. Clin Exp Pharmacol Physiol. 2000;27:639–641
  28. Leskinen Y, Lehtimaki T, Loimaala A, et al. Carotid atherosclerosis in chronic renal failure—The central role of increased plaque burden. Atherosclerosis. 2003;171:295–302
  29. Zhang L, Zhao F, Yang Y, et al. Association between carotid artery intima-media thickness and early-stage CKD in a Chinese population. Am J Kidney Dis. 2007;49:786–792
  30. Briet M, Bozec E, Laurent S, et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int. 2006;69:350–357
  31. Bild DE, Bluemke DA, Burke GL, et al. Multi-Ethnic Study of Atherosclerosis: Objectives and design. Am J Epidemiol. 2002;156:871–881
  32. Erlandsen EJ, Randers E, Kristensen JH. Evaluation of the Dade Behring N Latex Cystatin C assay on the Dade Behring Nephelometer II System. Scand J Clin Lab Invest. 1999;59:1–8
  33. Finney H, Newman DJ, Price CP. Adult reference ranges for serum cystatin C, creatinine and predicted creatinine clearance. Ann Clin Biochem. 2000;37:49–59
  34. Stevens LA, Coresh J, Schmid CH, et al. Estimating GFR using serum cystatin C alone and in combination with serum creatinine: A pooled analysis of 3,418 individuals with CKD. Am J Kidney Dis. 2008;51:395–406
  35. Shlipak MG, Fried LF, Cushman M, et al. Cardiovascular mortality risk in chronic kidney disease: Comparison of traditional and novel risk factors. JAMA. 2005;293:1737–1745
  36. Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–2100
  37. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  38. Watanabe S, Okura T, Liu J, et al. Serum cystatin C level is a marker of end-organ damage in patients with essential hypertension. Hypertens Res. 2003;26:895–899
  39. Rodondi N, Yerly P, Gabriel A, et al. Microalbuminuria, but not cystatin C, is associated with carotid atherosclerosis in middle-aged adults. Nephrol Dial Transplant. 2007;22:1107–1114
  40. Kramer H, Jacobs DR, Bild D, et al. Urine albumin excretion and subclinical cardiovascular disease (The Multi-Ethnic Study of Atherosclerosis). Hypertension. 2005;46:38–43
  41. Ix JH, Shlipak M, Katz R, et al. Kidney function and aortic valve and mitral annular calcification in the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis. 2007;50:412–420
  42. Ix JH, Katz R, Kestenbaum B, et al. Association of mild to moderate kidney dysfunction and coronary calcification. J Am Soc Nephrol. 2008;19:579–585
  43. Moran A, Katz R, Jenny NS, et al: Left ventricular hypertrophy in mild and moderate reduction in kidney function determined using cardiac magnetic resonance imaging and cystatin C: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis (in press)
  44. Singh D, Whooley MA, Ix JH, Ali S, Shlipak MG. Association of cystatin C and estimated GFR with inflammatory biomarkers: The Heart and Soul Study. Nephrol Dial Transplant. 2007;22:1087–1092
  45. Knight EL, Verhave JC, Spiegelman D, et al. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int. 2004;65:1416–1421
  46. Keller CR, Odden MC, Fried LF, et al. Kidney function and markers of inflammation in elderly persons without chronic kidney disease: The Health, Aging, and Body Composition Study. Kidney Int. 2007;71:239–244
  47. Shlipak MG, Katz R, Cushman M, et al. Cystatin-C and inflammatory markers in the ambulatory elderly. Am J Med. 2005;118:1416.e25–1416.e31
  48. Peralta CA, Whooley MA, Ix JH, Shlipak MG. Kidney function and systolic blood pressure new insights from cystatin C: Data from the Heart and Soul Study. Am J Hypertens. 2006;19:939–946
  49. Ix JH, Shlipak MG, Chertow GM, Whooley MA. Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: Data from the Heart and Soul Study. Circulation. 2007;115:173–179
  50. Demer LL, Tintut Y, Parhami F. Novel mechanisms in accelerated vascular calcification in renal disease patients. Curr Opin Nephrol Hypertens. 2002;11:437–443

 Originally published online as doi:10.1053/j.ajkd.2008.06.025 on September 29, 2008.

 Because the Editor-in-Chief recused himself from consideration of this manuscript, the peer-review and decision-making processes were handled entirely by a Co-Editor (Wolfgang C. Winkelmayer, MD, ScD, Harvard Medical School) who served as Acting Editor-in-Chief. Details of the journal's procedures for potential editor conflicts are given in the Editorial Policies section of the AJKD website.

PII: S0272-6386(08)01175-X

doi: 10.1053/j.ajkd.2008.06.025

American Journal of Kidney Diseases
Volume 53, Issue 3 , Pages 389-398 , March 2009

Article Tools

* Image Usage & Resolution